IGF1 and metabolic dysfunction-associated steatotic liver disease: Kaplan-Meier curve graphs confirmed that patients in the group with reduced IGF-1 and elevated IGF-1 levels at baseline had a greater likelihood of suffering NAFLD compared to patients in the normal IGF-1 group (log-rank test, P < 0.001) (Figure 2).